DrugPatentWatch Database Preview

Baxter Hlthcare Company Profile

BAXTER HLTHCARE has one hundred and ninety-four approved drugs.

There are five US patents protecting BAXTER HLTHCARE drugs. There are two tentative approvals on BAXTER HLTHCARE drugs.

There are eighty-seven patent family members on BAXTER HLTHCARE drugs in thirty-two countries and one hundred and sixty-three supplementary protection certificates in twelve countries.

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare	POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER	calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate	INJECTABLE;INJECTION	019367-008	Apr 5, 1985	AP	RX	No	No		➤ Sign Up				➤ Sign Up
Baxter Hlthcare	DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER	calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate	SOLUTION;INTRAPERITONEAL	020163-003	Dec 4, 1992	AT	RX	No	No		➤ Sign Up				➤ Sign Up
Baxter Hlthcare	IRRIGATING SOLUTION G IN PLASTIC CONTAINER	citric acid; magnesium oxide; sodium carbonate	SOLUTION;IRRIGATION	018519-001	Jun 22, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare	ETHRANE	enflurane	LIQUID;INHALATION	017087-001	Approved Prior to Jan 1, 1982	3,469,011	➤ Sign Up
Baxter Hlthcare	BREVIBLOC	esmolol hydrochloride	INJECTABLE;INJECTION	019386-003	Aug 15, 1988	5,017,609*PED	➤ Sign Up
Baxter Hlthcare	IFEX	ifosfamide	INJECTABLE;INJECTION	019763-002	Dec 30, 1988	3,732,340	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags	➤ Subscribe	2014-01-31
➤ Subscribe	Inhalation	99.90%	➤ Subscribe	2008-09-11

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
90006-4	Sweden	➤ Sign Up	PRODUCT NAME: ACETYLSALICYLSYRA OCH ESOMEPRAZOLMAGNESIUMTRIHYDRAT; NAT. REG. NO/DATE: MTNR 44371 20110930; FIRST REG.: PT 5402359MFL 20110812
1304992/01	Switzerland	➤ Sign Up	PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
90018-6	Sweden	➤ Sign Up	PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150119
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.